Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Percival Barretto-Ko is listed as Biotech Board Director | CEO at Spruce Biosciences, based in San Francisco Bay Area, United States. AeroLeads shows a matched LinkedIn profile for Percival Barretto-Ko.
Percival Barretto-Ko previously worked as Independent Director | Board of Directors at Spruce Biosciences and Independent Director | Board of Directors at Alessa Therapeutics, Inc.. Percival Barretto-Ko holds Sloan Fellow, Innovation And Global Leadership from Massachusetts Institute Of Technology.
This section adds company-level context without repeating Percival Barretto-Ko's masked contact details.
Review company-level records connected to Percival Barretto-Ko before choosing the right outreach path.
Percival Barretto-Ko is a Biotech Board Director | CEO at Spruce Biosciences.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
South San Francisco, California, Us
Spruce Biosciences (Nasdaq: SPRB) is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare diseases with significant unmet medical needs.
San Carlos, California, Us
Alessa Therapeutics, Inc. is a clinical-stage biotech company focused on the development and commercialization of selective and sustained localized drug delivery for early interception of cancer and other diseases.
Stamford, Ct, Us
Americares is a global non-profit organization focused on health and development that responds to individuals affected by poverty, disaster, or crisis. The organization addresses poverty, disasters, or crises with medicine, medical supplies, and health programs.
San Diego, California, Us
Plexium Inc. is a clinical-stage Targeted Protein Degradation (TPD) company seeking to discover monovalent direct degraders and molecular glues that address difficult-to-drug targets for the treatment of cancer and neurological diseases. The company's proprietary drug discovery platform is designed to identify novel small molecules that induce selective degradation of pathogenic proteins through E3 ligase mediated proteasomal degradation.
Spearheaded the execution of Astellas’ Corporate Strategic Plan and the company's efforts to enhance internal and external innovation. Led Business Development, Alliance Management, Advanced Informatics & Analytics, Intellectual Property, Patient Centricity, Information Systems, iota Biosciences, Rx+ Business Accelerator, and the Transformation Office.
Led Astellas Pharma's operations across the United States, headquartered in Northbrook, IL, with over $4.5 Billion in annual revenues. Member of the Board of Directors of the Pharmaceutical Research and Manufacturers of America (PhRMA).
Switzerland 🇨🇭 , Ch
The Roche Leadership Development Program (LDP) identifies and develops high-potential Roche executives for leadership positions through rotational assignments in a variety of key roles globally.
Quick answers generated from the profile data available on this page.
Percival Barretto-Ko works for Spruce Biosciences.
Percival Barretto-Ko is listed as Biotech Board Director | CEO at Spruce Biosciences.
Percival Barretto-Ko is based in San Francisco Bay Area, United States while working with Spruce Biosciences.
Percival Barretto-Ko has worked for Spruce Biosciences, Alessa Therapeutics, Inc., Americares, Plexium, and Astellas Pharma Inc..
You can use AeroLeads to view verified contact signals for Percival Barretto-Ko at Spruce Biosciences, including work email, phone, and LinkedIn data when available.
Percival Barretto-Ko holds Sloan Fellow, Innovation And Global Leadership from Massachusetts Institute Of Technology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts